Yonsa

Active Ingredient(s): Abiraterone Acetate
FDA Approved: * May 22, 2018
Pharm Company: * SUN PHARMA GLOBAL
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Yonsa Overview

Abiraterone, developmental code name CB-7598, also known as 17-(3-pyridyl)androsta-5,16-dien-3β-ol, is a synthetic, steroidal CYP17A1 inhibitor. It is the active metabolite of abiraterone acetate, an ester and prodrug of abiraterone. A metabolite of abiraterone has been found to act as an agonist of the androgen receptor, and may antagonize the clinical effectiveness of abiraterone acetate.[1] Abiraterone acetate Main article: Abiraterone acetate Abiraterone acetate (b...

Read more Yonsa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abiraterone

Recent Yonsa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Yonsa: (1 result)

Sorted by National Drug Code

• 47335-401 Yonsa 125 mg Oral Tablet by Sun Pharma Global Fze

Other drugs which contain Abiraterone Acetate or a similar ingredient: (2 results)

• ABIRATERONE ACETATE 1 discussion
• ZYTIGA Abiraterone Acetate5 discussions